Clinical Trials Browser

Not yet recruiting × selinexor × Lymphoid × Clear all

NCT06573138 2024-08-27

Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL

Phase 2 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell

NCT06573151 2024-08-27

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Phase 2 Not yet recruiting

Lymphoma